A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

Telehealth study of patient portal e-visits by Medicare participants shows few had an interaction for which their provider billed them.

Most people with risk factors for cardiovascular disease – what are sometimes called the Essential Eight – are managed by primary care clinics, or haven’t seen any provider recently

Around 10% of all deaths following percutaneous coronary intervention are potentially preventable, a study led by Michigan Medicine finds.

New website to help adolescents with disabilities learn about reproductive health.

Cardiologist shares how weight loss medications may impact cardiovascular health.

Cases of kidney stones in children are increasing, but parents can minimize the chances their kids develop them.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

A Michigan Medicine urogynecologist discusses what urinary tract infections are, how they are treated and what new research is on the horizon.

For people with expensive prescription drugs, switching plans could save them thousands of dollars in copays. And a simple tool can help people easily compare out-of-pockets expenses for anyone with a Medicare Part D prescription plan.

A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a Michigan Medicine study finds.

There are 13 U-M graduate medical education programs ranked in the top 10 by Doximity.

Tips and advice for translating health research findings into relevant, timely and compelling information

Michigan Medicine study shows model that predicts patient deterioration defies traditional challenges.